TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
GlaxoSmithKline ( (GB:GSK) ) has provided an announcement.
GSK plc announced the repurchase of 170,000 of its ordinary shares as part of its ongoing buyback program, with shares purchased at prices ranging from 1,775.50p to 1,793.50p. This transaction, executed through BNP Paribas SA, increases the total number of shares held in treasury to 235,772,844, representing 5.78% of the company’s voting rights. The buyback program aims to optimize the company’s capital structure and return value to shareholders, potentially impacting market perceptions and shareholder interests.
The most recent analyst rating on (GB:GSK) stock is a Hold with a £16.60 price target. To see the full list of analyst forecasts on GlaxoSmithKline stock, see the GB:GSK Stock Forecast page.
Spark’s Take on GB:GSK Stock
According to Spark, TipRanks’ AI Analyst, GB:GSK is a Outperform.
GlaxoSmithKline’s strong technical indicators and positive earnings call sentiment are the most significant factors driving the high score. The company’s solid financial performance, despite some concerns about cash flow and debt reliance, supports a favorable outlook. Valuation metrics further enhance its attractiveness, making GSK a compelling investment in the drug manufacturing sector.
To see Spark’s full report on GB:GSK stock, click here.
More about GlaxoSmithKline
GlaxoSmithKline (GSK) is a global healthcare company that specializes in pharmaceuticals, vaccines, and consumer healthcare products. It operates in the pharmaceutical industry with a focus on developing innovative medicines and vaccines for a variety of health conditions.
Average Trading Volume: 8,546,353
Technical Sentiment Signal: Buy
Current Market Cap: £72.21B
See more data about GSK stock on TipRanks’ Stock Analysis page.